Article

A Self-Assembled Viral Protein VP1 Induces Protective Immunity Against Coxsackievirus B3 (CVB3) Lethal Challenges in Balb/c Mice Model

2025-12-12

Abstract excerpt

Epidemiological studies have proven that coxsackievirus B3 (CVB3) is the major virus that cause acute and chronic viral myocarditis and cardiomyopathy. Currently, there are no antiviral therapeutic drugs or vaccines to be used as clinical therapeutic or vaccine. Virus-like particles (VLP) based vaccines offer a safe and effective vaccine platforms because of their structural similarity to native viruses, but lack...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 16787f2d-7ff7-55b2-8c06-54734b2639ef
DOI: 10.20944/preprints202512.1102.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Self-Assembled Viral Protein VP1 Induces Protective Immunity Against Coxsackievirus B3 (CVB3) Lethal Challenges in Balb/c Mice ModelDOI 10.20944/preprints202512.1102.v1Read

Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection.Semantic proximity Read

Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis.Semantic proximity Read

Comparison of structure and immunogenicity of CVB1-VLP and inactivated CVB1 vaccine candidatesSemantic proximity Read

Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis.Semantic proximity Read

Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.Semantic proximity Read

Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of AlphavirusSemantic proximity Read

Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in miceSemantic proximity Read

A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.Semantic proximity Read

Screening of a potential coxsackievirus B4 vaccine strain through analysis of biological featuresSemantic proximity Read

Virus-Like Particles: Applications in Reverse VaccinologySemantic proximity Read

Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infectionsSemantic proximity Read

Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.Semantic proximity Read